tradingkey.logo
tradingkey.logo
Search

Jasper Therapeutics Inc

JSPR
Add to Watchlist
0.630USD
+0.009+1.48%
Close 07-31 16:00ETQuotes delayed by 15 min
17.64MMarket Cap
LossP/E TTM

JSPR Financials

See Jasper Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Jasper Therapeutics Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.04/-0.49
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-3.95
19.07%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
97.10%-0.04
80.47%-0.32
9.35%-1.13
-79.09%-1.74
-37.35%-1.41
-7.98%-1.62
22.30%-1.24
33.91%-0.97
36.35%-1.03
58.37%-1.50
---1.60
---1.47
---1.62
---3.60
---6.72
----
----
----
----
----
Net Profit
94.47%-1.17M
62.58%-9.10M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.40M
77.37%-2.21M
9.31%-9.06M
68.48%-3.41M
---8.41M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Operating profit
49.77%-10.95M
41.71%-14.74M
3.64%-19.17M
-69.30%-27.08M
-44.65%-21.80M
-42.65%-25.29M
-2.72%-19.89M
10.29%-15.99M
-8.07%-15.07M
-28.94%-17.73M
-52.36%-19.36M
-49.02%-17.83M
-9.15%-13.95M
-13.78%-13.75M
-26.08%-12.71M
-42.11%-11.96M
-104.32%-12.78M
-102.79%-12.08M
-67.76%-10.08M
---8.42M
Net Profit
94.47%-1.17M
62.58%-9.10M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.40M
77.37%-2.21M
9.31%-9.06M
68.48%-3.41M
---8.41M
Current assets
-61.84%20.29M
-54.30%34.65M
-42.45%54.56M
-60.47%42.97M
-55.80%53.17M
-14.76%75.81M
-9.90%94.81M
-8.34%108.68M
-9.21%120.31M
113.12%88.94M
100.76%105.22M
87.35%118.57M
79.55%132.51M
-52.49%41.73M
-48.82%52.41M
252.12%63.29M
--73.80M
--87.83M
--102.41M
--17.97M
Total current liabilities
-27.06%9.00M
-13.37%13.20M
68.88%21.04M
103.62%20.50M
38.34%12.33M
23.14%15.24M
4.64%12.46M
12.22%10.07M
12.98%8.92M
75.15%12.37M
60.44%11.91M
35.49%8.97M
32.22%7.89M
-11.91%7.07M
-18.98%7.42M
-27.65%6.62M
--5.97M
--8.02M
--9.16M
--9.15M
Total assets
-63.22%21.18M
-55.22%35.78M
-42.19%57.47M
-59.21%46.47M
-54.27%57.60M
-15.80%79.90M
-9.96%99.41M
-8.25%113.93M
-9.22%125.96M
96.22%94.89M
86.78%110.41M
76.46%124.17M
72.27%138.76M
-48.36%48.36M
-44.87%59.11M
169.69%70.37M
--80.55M
--93.65M
--107.21M
--26.09M
Total liabilities
15.83%17.78M
73.54%31.63M
191.73%45.90M
68.62%22.96M
20.58%15.35M
10.78%18.23M
-3.31%15.73M
-2.48%13.62M
-6.09%12.73M
32.98%16.45M
40.94%16.27M
20.54%13.96M
8.97%13.56M
-48.74%12.37M
-59.65%11.54M
-6.90%11.59M
--12.44M
--24.14M
--28.61M
--12.44M
Total equity
-91.95%3.40M
-93.27%4.15M
-86.17%11.57M
-76.57%23.50M
-62.69%42.24M
-21.37%61.67M
-11.10%83.68M
-8.98%100.31M
-9.56%113.23M
117.96%78.44M
97.90%94.13M
87.48%110.20M
83.83%125.20M
-48.23%35.99M
-39.49%47.56M
330.69%58.78M
--68.11M
--69.52M
--78.60M
--13.65M
Net operating income
36.31%-14.55M
-3.47%-21.87M
-20.97%-17.00M
-32.30%-15.45M
-45.16%-22.84M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
-30.31%-16.48M
-24.25%-11.98M
-41.86%-13.27M
27.28%-10.34M
13.29%-12.65M
-35.66%-9.64M
-61.56%-9.36M
-129.43%-14.21M
-170.42%-14.58M
10.33%-7.11M
---5.79M
Net investment
-100.00%0.00
100.00%0.00
100.00%0.00
100.64%1.00K
116.00%4.00K
66.96%-76.00K
---274.00K
-1327.27%-157.00K
3.85%-25.00K
-180.49%-230.00K
100.00%0.00
95.47%-11.00K
10.34%-26.00K
88.47%-82.00K
52.77%-222.00K
15.33%-243.00K
96.98%-29.00K
---711.00K
---470.00K
---287.00K
Net financing
----
-198.55%-340.00K
315322.22%28.39M
3304.97%6.16M
-100.00%0.00
227.31%345.00K
-75.00%9.00K
159.34%181.00K
-53.36%47.35M
-1067.86%-271.00K
3500.00%36.00K
-2446.15%-305.00K
780753.85%101.51M
103.08%28.00K
-100.00%1.00K
102.17%13.00K
-99.88%13.00K
-108.41%-909.00K
--91.73M
---600.00K

FAQs

What are the current assets of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its current assets were 34.65M, with a year-on-year change of -54.30.

What are the total assets of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its total assets of Jasper Therapeutics Inc were 35.78M, with a year-on-year change of -55.22.

What are the total liabilities of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its total liabilities of Jasper Therapeutics Inc were 31.63M, with a year-on-year change of 73.54.

What is the total equity of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its total equity of Jasper Therapeutics Inc was 4.15M, with a year-on-year change of -93.27.

What is the net operating income of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its net operating income of Jasper Therapeutics Inc was -82.78M, with a year-on-year change of -8.58.

What is the net investment of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its net investment of Jasper Therapeutics Inc was 5.00K, with a year-on-year change of 100.94.

What is the net financing of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its net financing of Jasper Therapeutics Inc was 34.21M, with a year-on-year change of -28.55.

What is the Earnings Per Share (EPS) of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.95, with a year-on-year change of 19.07.

What is the net income of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its net income was -75.80M, with a year-on-year change of -6.36.

What is the Return on Equity (ROE) of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -230.31, with a year-on-year change of -126.39.

What is the Return on Assets (ROA) of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -131.06, with a year-on-year change of -60.71.

What is the operating profit of Jasper Therapeutics Inc?

According to Jasper Therapeutics Inc's FY2025 earnings report, its operating profit was -82.78M, with a year-on-year change of -8.58.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.